U.S. markets open in 8 hours 59 minutes
  • S&P Futures

    4,249.75
    +4.00 (+0.09%)
     
  • Dow Futures

    34,488.00
    +26.00 (+0.08%)
     
  • Nasdaq Futures

    14,019.00
    +24.75 (+0.18%)
     
  • Russell 2000 Futures

    2,332.70
    +2.20 (+0.09%)
     
  • Crude Oil

    71.28
    +0.37 (+0.52%)
     
  • Gold

    1,863.50
    -16.10 (-0.86%)
     
  • Silver

    27.93
    -0.22 (-0.77%)
     
  • EUR/USD

    1.2102
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    1.4620
    -1.4590 (-100.00%)
     
  • Vix

    15.65
    -16.10 (-100.00%)
     
  • GBP/USD

    1.4112
    -0.0005 (-0.03%)
     
  • USD/JPY

    109.7540
    +0.1190 (+0.11%)
     
  • BTC-USD

    39,142.36
    +4,159.09 (+11.89%)
     
  • CMC Crypto 200

    975.70
    +33.89 (+3.60%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • Nikkei 225

    29,117.92
    +169.19 (+0.58%)
     

The ICU Medical (NASDAQ:ICUI) Share Price Is Up 104% And Shareholders Are Boasting About It

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For example, the ICU Medical, Inc. (NASDAQ:ICUI) share price has soared 104% in the last half decade. Most would be very happy with that. It's down 1.7% in the last seven days.

View our latest analysis for ICU Medical

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During five years of share price growth, ICU Medical achieved compound earnings per share (EPS) growth of 7.9% per year. This EPS growth is lower than the 15% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. And that's hardly shocking given the track record of growth. This optimism is visible in its fairly high P/E ratio of 50.12.

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

earnings-per-share-growth
earnings-per-share-growth

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

A Different Perspective

Investors in ICU Medical had a tough year, with a total loss of 4.4%, against a market gain of about 58%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 15%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. It's always interesting to track share price performance over the longer term. But to understand ICU Medical better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with ICU Medical , and understanding them should be part of your investment process.

Of course ICU Medical may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.